1992
DOI: 10.1016/0306-4522(92)90404-p
|View full text |Cite
|
Sign up to set email alerts
|

Recovery from unilateral 6-hydroxydopamine lesion of substantia nigra promoted by the neurotachykinin substance P1–11

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
29
0
1

Year Published

1993
1993
2009
2009

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(31 citation statements)
references
References 64 publications
1
29
0
1
Order By: Relevance
“…Secondly, it has been demonstrated that several neuropeptides can promote processes related to functional recovery following CNS damage (Dekker et al 1987;Pitsikas et al 1991;Mattioli et al 1992;Lestage et al 1998a) and display neurotrophic actions in vitro (Iwasaki et al 1989;Whitty et al 1993). Thirdly, a number of neuropeptides are also found to be reduced in aged animals and humans (Buck et al 1981;Dupont et al 1981;Wang et al 1981).…”
mentioning
confidence: 99%
“…Secondly, it has been demonstrated that several neuropeptides can promote processes related to functional recovery following CNS damage (Dekker et al 1987;Pitsikas et al 1991;Mattioli et al 1992;Lestage et al 1998a) and display neurotrophic actions in vitro (Iwasaki et al 1989;Whitty et al 1993). Thirdly, a number of neuropeptides are also found to be reduced in aged animals and humans (Buck et al 1981;Dupont et al 1981;Wang et al 1981).…”
mentioning
confidence: 99%
“…2 (Flohr & Ltineburg, 1982;Igarashi et al, 1985;Mattioli et al, 1992;Antonawich et al, 1993;Bannon et al, 1995;Sprick et al, 1996). Such promotive effects might be due to their known neurotrophic effects (Jonsson & Hallman, 1982;Nyakas et al, 1985;van der Neut et al, 1988;Iwasaki et al, 1989;Kowall et al, 1991).…”
Section: Resultsmentioning
confidence: 99%
“…bilateral adjustments in the activity of vestibular nuclei (Flohr & Beinhold, 1981;Sans et al, 1997), modulation of the lesion side via commissural interconnections (Dieringer & Precht, 1979), cerebellar input to the vestibular neurons (Dieringer & Precht, 1979), and neurochemical modulation via cholinergic systems (Beinhold & Flohr, 1980 (Schaefer & Meyer, 1974) to promote functional recovery after brain lesions (Mattioli et al, 1992;Bannon et al, 1995) and to act in a neurotrophic and neuroprotective way (Jonsson & Hallman, 1982;Iwasaki et al, 1989;Kowall et al, 1991;Mattioli et al, 1992;Nikolaus et al, 1999). ACTH4-10 can also accelerate recovery after hemilabyrithectomy in frogs (Flohr & Liineburg, 1982) and monkeys (Igarashi et al;1985) and after lesions of the CNS (Antonawich et al, 1993; for review see van Rijzingen et al, 1996).…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, it has been hypothesized that manipulation of substance P-ergic system may have therapeutic effects in the treatment of Parkinson's disease. Indeed, in animal model of Parkinson's disease, it has been shown that pre- or post-treatment with substance P or its C-terminal can promote functional recovery in partial nigrostriatal dopamine lesions (Mattioli et al, 1992; Nikolaus et al, 1997, 1999). However, up to now, the reasons for substance P-induced neuroprotection for Parkinson's disease are unclear.…”
Section: Discussionmentioning
confidence: 99%